Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era
Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/
Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through battle-tested AI Agents at enterprise scale.
The new funds will accelerate the adoption of the Torq AI SOC Platform, the only end-to-end solution built on the pillars of advanced Hyperautomation, Alert Triage, and Fatigue Reduction to deliver full operational autonomy for global enterprises and government agencies.
“Torq is redefining security operations,” said Shay Michel, Managing Partner, Merlin Ventures. “They’ve fused automation and human judgment into a new AI SOC Platform built for asymmetric threats and real-world scale. This is why Merlin is leading the investment. Our focus now is speed—accelerating go-to-market, expanding across commercial and government markets, and building the next global category leader in AI security operations.”
Torq Delivers On the Promise of the AI SOC
“This funding accelerates our mission to define and dominate the AI SOC market. We are moving far beyond the constraints of legacy SOAR and SIEM, harnessing the Agentic AI Era to deliver outcomes our customers rely on,” said Ofer Smadari, CEO and co-founder, Torq. “Global enterprise adoption of our AI SOC Platform has validated our vision for the future of security operations. We have achieved tremendous revenue growth, with Fortune 100 customers adopting our AI Agents in their SOCs for everything from investigation to response. Our partnership with Merlin Ventures is the definitive signal that Torq is now ready to scale this massive customer success into the high-stakes Federal and Public Sector markets.”
The Growth Engine: Massive AI Agent Adoption
The primary driver behind Torq’s 2025 growth is the unprecedented adoption of its AI Agents across its global customer base. Unlike legacy security tools that require extensive professional services, Torq AI Agents are designed for self-service, enabling security teams to build and deploy sophisticated agents with minimal effort.
Today, Torq AI Agents are deeply embedded in the daily operations of Fortune 500 SOCs, managing millions of complex security tasks autonomously. This "bottom-up" adoption has transformed Torq from a specialized tool into the primary platform for the modern SOC.
“Torq delivers fast, measurable value to Valvoline’s SOC and eliminates the manual tasks that once consumed our analysts’ time,” said Corey Kaemming, CISO, Valvoline. “Within 48 hours of deployment, our team was using Torq’s AI SOC Platform for automating phishing triage, accelerating alert handling, and reducing response times across the board. The results were transformative. Analysts reclaimed hours of time, containment actions became automatic, and the security team evolved from reactive responders to proactive strategists. Torq took the vision that was in our heads and actually put it into practice. My team is in love with Torq.”
Strategic Expansion Into the Federal Market
Torq's partnership with lead investor Merlin Ventures has accelerated Torq’s traction within the U.S. Federal and Public Sector markets. With nearly 30 years of success bringing technologies to the U.S. government market, Merlin Ventures provides Torq with the strategic support and deep government relationships necessary to navigate complex compliance requirements, including FedRAMP, and rapidly scale the Torq AI SOC Platform to protect the nation's most critical infrastructure.
Explosive Growth and Enterprise Maturity Validation
The Series D affirms Torq’s proven market traction and maturity. In 2025 alone, the company delivered significant customer expansion, demonstrating that the Torq AI SOC Platform is built for complex, multinational security environments. Torq now protects hundreds of multinational enterprises, including Marriott, PepsiCo, Procter & Gamble, Siemens, Uber, and Virgin Atlantic.
Torq Leads the Shift To AI Agents: Autonomous Investigations and Advanced Automation
Torq is driving this transformation through its singular Agentic AI foundation. In 2025, Torq solidified its market lead by delivering the most advanced multi-agent security capabilities, backed by the strategic acquisition of RevRod. This proven platform empowers SOC teams through two critical product pillars:
- 100% Triage and Alert investigation: Achieves immediate triage on low-fidelity alerts, cutting investigation time by up to 90%, and ensuring human analysts only focus on verified, high-impact threats.
- Self-Service Agentic Platform: Provides an end-to-end Agent builder that enables teams to manage 100X more alerts without increasing headcount. The ability for customers to build their own agents with minimal effort has led to massive, SOC-wide usage that is now the industry standard.
“We’re always innovating our security operations approach at Virgin Atlantic and the Torq AI SOC Platform is driving significant benefits for us,” said John White, CISO, Virgin Atlantic. “Today, innovation stems from an AI-first approach, which Torq excels at. Torq is making our security operations simpler and more efficient, and providing us with complete coverage across our security stack. Torq is now our umbrella platform.”
About Torq
Torq is transforming cybersecurity with the Torq AI SOC platform. Torq empowers enterprises to instantly and precisely detect and respond to security events at scale. Torq’s customer base includes major multinational enterprise customers, including Abnormal Security, Armis, Check Point Security, Chipotle Mexican Grill, Inditex (Zara, Bershka, and Pull & Bear), Informatica, Kyocera, PepsiCo, Procter & Gamble, Siemens, Telefonica, Valvoline, Virgin Atlantic, and Wiz.
About Merlin Ventures
Merlin Ventures is the venture capital affiliate of Merlin Group, a network of companies with nearly 30 years of success bringing technologies to the U.S. government market. Merlin Ventures rapidly scales visionary companies and introduces disruptive solutions designed to help enterprises address today's most critical cybersecurity challenges. Its unique business model combines robust infrastructure and capital, technical advisory and engineering advisory, market readiness acceleration, and deep-rooted government and industry relationships that enable its portfolio to rapidly grow and scale. Learn more at merlin.vc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260112510774/en/
Contacts
Media Contact
torq@teamhighwire.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom